TELENZEPINE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C19H22N4O2S
Molecular Weight	370.469
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CN1CCN(CC(=O)N2C3=C(C)SC=C3C(=O)NC4=CC=CC=C24)CC1

InChI

InChIKey=VSWPGAIWKHPTKX-UHFFFAOYSA-N

InChI=1S/C19H22N4O2S/c1-13-18-14(12-26-13)19(25)20-15-5-3-4-6-16(15)23(18)17(24)11-22-9-7-21(2)8-10-22/h3-6,12H,7-11H2,1-2H3,(H,20,25)

HIDE SMILES / InChI

Molecular Formula	C19H22N4O2S
Molecular Weight	370.469
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2695806 | https://www.ncbi.nlm.nih.gov/pubmed/8081076 | https://adisinsight.springer.com/drugs/800000603

Telenzepine is a selective muscarinic M1 receptor antagonist that was studied for selective inhibition of gastric acid secretion. Telenzepine was used in clinical trials in patients with acute duodenal ulcer, where was found that once daily administration of 3 mg in the evening must be regarded as the optimal dosage regimen of telenzepine. However, the preregistration for peptic ulcer in Germany was discontinued. In addition, the drug was studied in patients with nocturnal asthma. It was shown that telenzepine via the oral route at a dose of up to 5 mg was not effective in preventing nocturnal asthma.

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Muscarinic acetylcholine receptor M1 169 Target ID: CHEMBL276 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2066986 \| https://www.ncbi.nlm.nih.gov/pubmed/2695806	Antagonist 2778		0.0018 µM [Ki]

PubMed

Title	Date	PubMed
The existence of stable enantiomers of telenzepine and their stereoselective interaction with muscarinic receptor subtypes.	1989 Apr	2704371
Assessment of the muscarinic receptor subtypes involved in pilocarpine-induced seizures in mice.	1994 Feb 28	8028781
Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats.	1999 Jan 1	9920179
Distinct muscarinic receptors enhance spontaneous GABA release and inhibit electrically evoked GABAergic synaptic transmission in the chick lateral spiriform nucleus.	2001	11457590
Inhibition of field stimulation-induced contractions of rabbit vas deferens by muscarinic receptor agonists: selectivity of McN-A-343 for M1 receptors.	2001 Apr	11341365
Miniaturization of fluorescence polarization receptor-binding assays using CyDye-labeled ligands.	2003 Aug	14567793
PMA decreases the proliferation of retinal cells in vitro: the involvement of acetylcholine and BDNF.	2003 Jan	12441170
Cholinergic modulation of memory in the basolateral amygdala involves activation of both m1 and m2 receptors.	2003 May	12799522
Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats.	2007 Apr	17255465
Segment-dependent expression of muscarinic acetylcholine receptors and G-protein coupling in the equine respiratory tract.	2007 Feb	17180451
Muscarinic preferential M(1) receptor antagonists enhance the discriminative-stimulus effects of cocaine in rats.	2007 Oct	17631384
Effect of muscarinic receptor agonists xanomeline and sabcomeline on acetylcholine and dopamine efflux in the rat brain; comparison with effects of 4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one (AC260584) and N-desmethylclozapine.	2008 Oct 31	18771666
Development of a homogeneous high-throughput live-cell G-protein-coupled receptor binding assay.	2008 Sep	18460694
Galantamine improves apomorphine-induced deficits in prepulse inhibition via muscarinic ACh receptors in mice.	2009 Jan	19133998
Secretion from acinar cells of the exocrine pancreas: role of enteropancreatic reflexes and cholecystokinin.	2009 Jan	18948215

Sample Use Guides

In Vivo Use Guide

120 patients with endoscopically proven, florid duodenal ulcer were treated with either 1.5 mg, 3 mg or 5 mg telenzepine once daily at bedtime (40 patients per dose group).

Route of Administration: Oral

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:32:36 UTC 2023` Edited by `admin` on `Fri Dec 15 16:32:36 UTC 2023`
Record UNII	0990EG3K10
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

TELENZEPINE

Official Name

English

NSC-758679

Code

English

10H-THIENO(3,4-B)(1,5)BENZODIAZEPIN-10-ONE, 4,9-DIHYDRO-3-METHYL-4-(2-(4-METHYL-1-PIPERAZINYL)ACETYL)-

Common Name

English

TELENZEPINE [MART.]

Common Name

English

telenzepine [INN]

Common Name

English

TELENZEPINE [MI]

Common Name

English

4,9-DIHYDRO-3-METHYL-4-(2-(4-METHYL-1-PIPERAZINYL)ACETYL)-10H-THIENO(3,4-B)(1,5)BENZODIAZEPIN-10-ONE

Systematic Name

English

Telenzepine [WHO-DD]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C29704